| 000 | 01057 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250514161220.0 | ||
| 264 | 0 | _c20040629 | |
| 008 | 200406s 0 0 eng d | ||
| 022 | _a1470-269X | ||
| 024 | 7 |
_a10.1038/sj.tpj.6500198 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWeatherall, D J | |
| 245 | 0 | 0 |
_aPharmacological treatment of monogenic disease. _h[electronic resource] |
| 260 |
_bThe pharmacogenomics journal _c2003 |
||
| 300 |
_a264-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnemia, Sickle Cell _xdrug therapy |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aGenetic Diseases, Inborn _xdrug therapy |
| 650 | 0 | 4 |
_aGenetic Markers _xgenetics |
| 650 | 0 | 4 |
_aHemoglobins _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aPhenylketonurias _xdrug therapy |
| 773 | 0 |
_tThe pharmacogenomics journal _gvol. 3 _gno. 5 _gp. 264-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.tpj.6500198 _zAvailable from publisher's website |
| 999 |
_c14325243 _d14325243 |
||